STEPHY.T.P, SREEJITH. K, Dr. BINDU G. Comparison of quality of life (QOL) for patients with breast Cancer receiving adjuvant tac (docetaxel, doxorubicin, Cyclophosphamide) and fac (5-fluorouracil, doxorubicin, Cyclophosphamide) therapy. ijpbs [Internet]. 2017 Sep. 30 [cited 2026 Sep. 3];8(3):373-82. Available from: https://ijpbs.net/index.php/journal/article/view/6006